G30 |
G30.9 |
Alzheimer’s disease |
4348 (1.2797) |
0.2672 |
0.0506 |
5.2861 |
4.7347–5.9017 |
F03 |
F03.90 |
Unspecified dementia |
13 895 (4.0895) |
0.2340 |
0.0456 |
5.1278 |
4.7678–5.5150 |
F02 |
F02.80 |
Dementia in other diseases classified elsewhere |
8684 (2.5558) |
0.2379 |
0.0485 |
4.9065 |
4.4977–5.3524 |
I10 |
I10. |
Essential (primary) hypertension |
208 817 (61.4580) |
0.0768 |
0.0159 |
4.8387 |
4.3920–5.3309 |
F01 |
F01.50 |
Vascular dementia |
6033 (1.7756) |
0.2342 |
0.0501 |
4.6786 |
4.2212–5.1856 |
Z66 |
Z66. |
Do not resuscitate |
6448 (1.8977) |
0.2244 |
0.0500 |
4.4864 |
4.0498–4.9700 |
R62 |
R62.7 |
Lack of expected normal physiological development in childhood and adults |
3414 (1.0048) |
0.2209 |
0.0516 |
4.2777 |
3.7238–4.9140 |
R54 |
R54. |
Age-related physical debility |
11 357 (3.3425) |
0.1983 |
0.0483 |
4.1040 |
3.7668–4.4714 |
C93 |
C93.10 |
Monocyte leukemia |
122 (0.0359) |
0.2131 |
0.0533 |
4.0005 |
1.9240–8.3180 |
D46 |
D46.9 |
Myelodysplastic syndromes |
755 (0.2222) |
0.2106 |
0.0530 |
3.9750 |
2.9513–5.3539 |
L89 |
L89.90 |
Pressure ulcer |
8092 (2.3816) |
0.1908 |
0.0500 |
3.8180 |
3.4499–4.2253 |
I13 |
I13.0 |
Hypertensive heart and chronic kidney disease |
9823 (2.8911) |
0.1844 |
0.0494 |
3.7299 |
3.3925–4.1008 |
J64 |
J64. |
Unspecified pneumoconiosis |
107 (0.0315) |
0.1963 |
0.0533 |
3.6833 |
1.6173–8.3882 |
C95 |
C95.90 |
Leukemia of unspecified cell type |
609 (0.1792) |
0.1938 |
0.0531 |
3.6505 |
2.5754–5.1743 |
R64 |
R64. |
Cachexia |
797 (0.2346) |
0.1932 |
0.0530 |
3.6457 |
2.6851–4.9499 |
E43 |
E43. |
Unspecified severe protein-calorie malnutrition |
1597 (0.4700) |
0.1904 |
0.0527 |
3.6133 |
2.9023–4.4984 |
Z74 |
Z74.09 |
Problems related to care provider dependency |
17 940 (5.2800) |
0.1681 |
0.0469 |
3.5822 |
3.3154–3.8704 |
D63 |
D63.1 |
Anemia in chronic diseases classified elsewhere |
14 823 (4.3626) |
0.1703 |
0.0480 |
3.5494 |
3.2667–3.8565 |
C24 |
C24.1 |
Malignant neoplasm of other and unspecified parts of biliary tract |
122 (0.0359) |
0.1885 |
0.0533 |
3.5383 |
1.6054–7.7983 |
F05 |
F05. |
Delirium due to known physiological condition |
3612 (1.0631) |
0.1822 |
0.0519 |
3.5070 |
3.0142–4.0803 |
Y95 |
Y95. |
Nosocomial condition |
355 (0.1045) |
0.1859 |
0.0532 |
3.4952 |
2.1891–5.5806 |
W06 |
W06.XXXA |
Fall from bed |
2167 (0.6378) |
0.1832 |
0.0525 |
3.4898 |
2.8768–4.2334 |
C78 |
C78.7 |
Secondary malignant neoplasm of respiratory and digestive organs |
1305 (0.3841) |
0.1839 |
0.0528 |
3.4814 |
2.7193–4.4570 |
J90 |
J90. |
Pleural effusion, not elsewhere classified |
5673 (1.6696) |
0.1754 |
0.0513 |
3.4218 |
3.0197–3.8774 |
J69 |
J69.0 |
Pneumonitis due to solids and liquids |
2896 (0.8523) |
0.1785 |
0.0523 |
3.4165 |
2.8812–4.0511 |
I50 |
I50.9 |
Heart failure |
36 427 (10.7210) |
0.1447 |
0.0424 |
3.4162 |
3.2021–3.6445 |
N18 |
N18.9 |
Chronic kidney disease |
48 428 (14.2531) |
0.1352 |
0.0397 |
3.4042 |
3.2006–3.6206 |
I75 |
I75.029 |
Atheroembolism |
138 (0.0406) |
0.1812 |
0.0533 |
3.4003 |
1.5879–7.2814 |
J81 |
J81.0 |
Pulmonary edema |
2462 (0.7246) |
0.1767 |
0.0524 |
3.3700 |
2.7995–4.0567 |
G20 |
G20. |
Parkinson’s disease |
5105 (1.5025) |
0.1732 |
0.0515 |
3.3623 |
2.9456–3.8379 |
N25 |
N25.81 |
Disorders resulting from impaired renal tubular function |
6475 (1.9057) |
0.1699 |
0.0511 |
3.3268 |
2.9515–3.7497 |
J96 |
J96.01 |
Respiratory failure, not elsewhere classified |
13 350 (3.9291) |
0.1624 |
0.0489 |
3.3231 |
3.0408–3.6316 |
I12 |
I12.9 |
Hypertensive chronic kidney disease |
26 422 (7.7764) |
0.1498 |
0.0452 |
3.3156 |
3.0895–3.5582 |
D02 |
D02.20 |
Carcinoma in situ of middle ear and respiratory system |
2023 (0.5954) |
0.1740 |
0.0526 |
3.3075 |
2.6919–4.0639 |
W07 |
W07.XXXA |
Fall from chair |
1948 (0.5733) |
0.1740 |
0.0526 |
3.3063 |
2.6807–4.0780 |
C94 |
C94.6 |
Other leukemias of specified cell type |
412 (0.1213) |
0.1748 |
0.0532 |
3.2860 |
2.0929–5.1592 |
N19 |
N19. |
Unspecified kidney failure |
7383 (2.1729) |
0.1663 |
0.0508 |
3.2729 |
2.9203–3.6680 |
L12 |
L12.0 |
Pemphigoid |
334 (0.0983) |
0.1737 |
0.0532 |
3.2634 |
1.9740–5.3952 |
R26 |
R26.9 |
Abnormalities of gait and mobility |
67 067 (19.7388) |
0.1202 |
0.0369 |
3.2578 |
3.0675–3.4598 |
Z49 |
Z49.31 |
Encounter for care involving renal dialysis |
1540 (0.4532) |
0.1714 |
0.0528 |
3.2472 |
2.5607–4.1178 |
I96 |
I96. |
Gangrene, not elsewhere classified |
2079 (0.6119) |
0.1708 |
0.0526 |
3.2459 |
2.6429–3.9864 |
H27 |
H27.8 |
Other specified disorders of lens |
6825 (2.0087) |
0.1642 |
0.0511 |
3.2170 |
2.8561–3.6236 |
I25 |
I25.10 |
Chronic ischemic heart disease |
77 259 (22.7385) |
0.1139 |
0.0355 |
3.2083 |
3.0212–3.4069 |
T66 |
T66.XXXA |
Radiation sickness, unspecified |
211 (0.0621) |
0.1706 |
0.0533 |
3.2036 |
1.6912–6.0686 |
C34 |
C34.90 |
Malignant neoplasm of bronchus and lung |
3805 (1.1199) |
0.1664 |
0.0520 |
3.1962 |
2.7354–3.7346 |
E46 |
E46. |
Unspecified protein–calorie malnutrition |
3568 (1.0501) |
0.1659 |
0.0521 |
3.1825 |
2.7098–3.7377 |
E44 |
E44.0 |
Protein–calorie malnutrition of moderate and mild degree |
3752 (1.1043) |
0.1647 |
0.0521 |
3.1623 |
2.7011–3.7022 |
C91 |
C91.10 |
Lymphoid leukemia |
1854 (0.5457) |
0.1661 |
0.0527 |
3.1517 |
2.5270–3.9307 |
N17 |
N17.9 |
Acute kidney failure |
31 785 (9.3548) |
0.1396 |
0.0444 |
3.1421 |
2.9347–3.3641 |
Z19 |
Z19.2 |
Hormone sensitivity malignancy status |
174 (0.0512) |
0.1667 |
0.0533 |
3.1286 |
1.5331–6.3847 |
L22 |
L22. |
Diaper dermatitis |
774 (0.2278) |
0.1654 |
0.0531 |
3.1159 |
2.2159–4.3814 |
G91 |
G91.2 |
Hydrocephalus |
917 (0.2699) |
0.1647 |
0.0530 |
3.1053 |
2.2680–4.2515 |
G92 |
G92. |
Toxic encephalopathy |
1085 (0.3193) |
0.1631 |
0.0530 |
3.0793 |
2.3025–4.1180 |
Y73 |
Y73.2 |
Gastroenterology and urology devices associated with adverse events |
735 (0.2163) |
0.1633 |
0.0531 |
3.0752 |
2.1619–4.3743 |
C79 |
C79.51 |
Secondary malignant neoplasm of other and unspecified sites |
2724 (0.8017) |
0.1612 |
0.0525 |
3.0721 |
2.5499–3.7014 |
Z96 |
Z96.1 |
Presence of other functional implants |
58 557 (17.2342) |
0.1206 |
0.0393 |
3.0656 |
2.8838–3.2588 |
E78 |
E78.5 |
Disorders of lipoprotein metabolism and other lipidemias |
223 873 (65.8892) |
0.0692 |
0.0226 |
3.0600 |
2.8037–3.3397 |
I73 |
I73.9 |
Other peripheral vascular diseases |
31 350 (9.2268) |
0.1369 |
0.0448 |
3.0545 |
2.8506–3.2730 |
R18 |
R18.8 |
Ascites |
2408 (0.7087) |
0.1586 |
0.0526 |
3.0172 |
2.4710–3.6840 |
C66 |
C66.9 |
Malignant neoplasm of ureter |
237 (0.0698) |
0.1603 |
0.0533 |
3.0107 |
1.6104–5.6286 |
Z95 |
Z95.1 |
Presence of cardiac and vascular implants and grafts |
34 407 (10.1265) |
0.1330 |
0.0444 |
2.9986 |
2.8020–3.2089 |
Z71 |
Z71.89 |
Persons encountering health services for other counseling and medical advice, not elsewhere classified |
308 757 (90.8718) |
0.0568 |
0.0190 |
2.9898 |
2.5115–3.5592 |
J91 |
J91.8 |
Pleural effusion in conditions classified elsewhere |
4873 (1.4342) |
0.1545 |
0.0519 |
2.9798 |
2.5795–3.4422 |
G11 |
G11.1 |
Hereditary ataxia |
586 (0.1725) |
0.1570 |
0.0532 |
2.9538 |
1.9729–4.4224 |
I48 |
I48.91 |
Atrial fibrillation and flutter |
35 951 (10.5809) |
0.1301 |
0.0442 |
2.9419 |
2.7502–3.1470 |
J15 |
J15.9 |
Bacterial pneumonia, not elsewhere classified |
9858 (2.9014) |
0.1482 |
0.0505 |
2.9350 |
2.6389–3.2644 |
N14 |
N14.0 |
Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions |
405 (0.1192) |
0.1556 |
0.0532 |
2.9235 |
1.7952–4.7611 |
I67 |
I67.89 |
Other cerebrovascular diseases |
16 692 (4.9127) |
0.1420 |
0.0487 |
2.9125 |
2.6714–3.1754 |
H26 |
H26.9 |
Other cataract |
60 786 (17.8902) |
0.1156 |
0.0398 |
2.9053 |
2.7326–3.0889 |
Y71 |
Y71.2 |
Cardiovascular devices associated with adverse incidents |
989 (0.2911) |
0.1537 |
0.0530 |
2.8978 |
2.1144–3.9715 |
J17 |
J17. |
Pneumonia in diseases classified elsewhere |
2185 (0.6431) |
0.1524 |
0.0527 |
2.8925 |
2.3345–3.5838 |
J61 |
J61. |
Pneumoconiosis due to asbestos and other mineral fibers |
1189 (0.3499) |
0.1531 |
0.0530 |
2.8892 |
2.1653–3.8551 |
T82 |
T82.818A |
Complications of cardiac and vascular prosthetic devices, implants, and grafts |
6593 (1.9404) |
0.1479 |
0.0515 |
2.8738 |
2.5282–3.2668 |
I95 |
I95.9 |
Hypotension |
32 131 (9.4566) |
0.1301 |
0.0453 |
2.8710 |
2.6771–3.0789 |
I70 |
I70.0 |
Atherosclerosis |
19 489 (5.7359) |
0.1379 |
0.0482 |
2.8613 |
2.6354–3.1065 |
I27 |
I27.20 |
Other pulmonary heart disease |
9999 (2.9429) |
0.1445 |
0.0506 |
2.8580 |
2.5677–3.1811 |
W90 |
W90.8XXA |
Exposure to other nonionizing radiation |
250 (0.0736) |
0.1520 |
0.0533 |
2.8541 |
1.5219–5.3522 |
I62 |
I62.00 |
Other and unspecified nontraumatic intracranial hemorrhage |
1571 (0.4624) |
0.1509 |
0.0529 |
2.8530 |
2.2142–3.6762 |
N40 |
N40.0 |
Benign prostatic hyperplasia |
85 767 (25.2425) |
0.1036 |
0.0363 |
2.8518 |
2.6852–3.0289 |
R65 |
R65.20 |
Symptoms and signs specifically associated with systemic inflammation and infection |
5450 (1.6040) |
0.1468 |
0.0518 |
2.8334 |
2.4613–3.2617 |
A41 |
A41.9 |
Other sepsis |
12 759 (3.7552) |
0.1412 |
0.0499 |
2.8303 |
2.5681–3.1193 |
C83 |
C83.30 |
Nonfollicular lymphoma |
1195 (0.3517) |
0.1498 |
0.0530 |
2.8268 |
2.1123–3.7829 |
L97 |
L97.509 |
Nonpressure chronic ulcer of lower limb, not elsewhere classified |
13 950 (4.1057) |
0.1401 |
0.0496 |
2.8231 |
2.5701–3.1010 |
I06 |
I06.0 |
Rheumatic aortic valve disease |
614 (0.1807) |
0.1498 |
0.0532 |
2.8189 |
1.8796–4.2275 |
C92 |
C92.10 |
Myeloid leukemia |
602 (0.1772) |
0.1495 |
0.0532 |
2.8123 |
1.8667–4.2369 |
G31 |
G31.84 |
Other degenerative diseases of nervous system, not elsewhere classified |
21 486 (6.3237) |
0.1343 |
0.0479 |
2.8064 |
2.5905–3.0402 |
G70 |
G70.00 |
Myasthenia gravis and other myoneural disorders |
745 (0.2193) |
0.1490 |
0.0531 |
2.8049 |
1.9386–4.0581 |
G21 |
G21.11 |
Secondary parkinsonism |
2043 (0.6013) |
0.1478 |
0.0528 |
2.8019 |
2.2364–3.5103 |
D61 |
D61.818 |
Other aplastic anemias and other bone marrow failure syndromes |
3153 (0.9280) |
0.1468 |
0.0525 |
2.7995 |
2.3311–3.3619 |
J70 |
J70.5 |
Respiratory conditions due to other external agents |
438 (0.1289) |
0.1484 |
0.0532 |
2.7891 |
1.7221–4.5172 |
R57 |
R57.0 |
Shock, not elsewhere classified |
1089 (0.3205) |
0.1478 |
0.0530 |
2.7881 |
2.0503–3.7914 |
I63 |
I63.9 |
Cerebral infarction |
18 075 (5.3197) |
0.1357 |
0.0487 |
2.7853 |
2.5572–3.0338 |
C19 |
C19. |
Malignant neoplasm of rectosigmoid junction |
547 (0.1610) |
0.1481 |
0.0532 |
2.7847 |
1.8074–4.2903 |
H25 |
H25.13 |
Age-related cataract |
127 537 (37.5361) |
0.0888 |
0.0320 |
2.7742 |
2.6054–2.9539 |
W08 |
W08.XXXA |
Fall from other furniture |
544 (0.1601) |
0.1471 |
0.0532 |
2.7653 |
1.7896–4.2730 |
Z75 |
Z75.1 |
Problems related to medical facilities and other care |
10 861 (3.1966) |
0.1394 |
0.0505 |
2.7610 |
2.4854–3.0672 |
S88 |
S88.119A |
Traumatic amputation of lower leg |
1412 (0.4156) |
0.1459 |
0.0529 |
2.7556 |
2.0985–3.6185 |
J84 |
J84.10 |
Other interstitial pulmonary diseases |
7398 (2.1773) |
0.1414 |
0.0514 |
2.7524 |
2.4303–3.1172 |
N08 |
N08. |
Glomerular disorders in diseases classified elsewhere |
2453 (0.7220) |
0.1443 |
0.0527 |
2.7400 |
2.2233–3.3768 |
I65 |
I65.29 |
Occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction |
16 848 (4.9586) |
0.1344 |
0.0491 |
2.7367 |
2.5052–2.9897 |
S78 |
S78.019A |
Traumatic amputation of hip and thigh |
447 (0.1316) |
0.1454 |
0.0532 |
2.7329 |
1.6860–4.4299 |
J92 |
J92.9 |
Pleural plaque |
1007 (0.2964) |
0.1450 |
0.0531 |
2.7326 |
1.9780–3.7751 |
I69 |
I69.898 |
Sequelae of cerebrovascular disease |
14 535 (4.2779) |
0.1356 |
0.0497 |
2.7310 |
2.4866–2.9995 |
D64 |
D64.9 |
Other anemias |
62 258 (18.3235) |
0.1103 |
0.0405 |
2.7201 |
2.5576–2.8930 |
S72 |
S72.009A |
Fracture of femur |
3337 (0.9821) |
0.1423 |
0.0524 |
2.7140 |
2.2641–3.2535 |
C80 |
C80.1 |
Malignant neoplasm without specification of site |
1345 (0.3959) |
0.1435 |
0.0530 |
2.7089 |
2.0438–3.5904 |
W05 |
W05.0XXA |
Fall from nonmoving wheelchair, nonmotorized scooter, and motorized mobility scooter |
660 (0.1942) |
0.1439 |
0.0532 |
2.7080 |
1.8148–4.0408 |
S98 |
S98.119A |
Traumatic amputation of ankle and foot |
1353 (0.3982) |
0.1434 |
0.0530 |
2.7069 |
2.0437–3.5853 |
R33 |
R33.9 |
Retention of urine |
20 323 (5.9814) |
0.1307 |
0.0484 |
2.7009 |
2.4861–2.9343 |
C71 |
C71.9 |
Malignant neoplasm of brain |
557 (0.1639) |
0.1436 |
0.0532 |
2.7007 |
1.7462–4.1768 |
J47 |
J47.9 |
Bronchiectasis |
1749 (0.5148) |
0.1424 |
0.0529 |
2.6928 |
2.1001–3.4529 |
D53 |
D53.9 |
Other nutritional anemias |
4238 (1.2473) |
0.1406 |
0.0522 |
2.6927 |
2.2886–3.1682 |
J44 |
J44.9 |
Other chronic obstructive pulmonary disease |
63 653 (18.7340) |
0.1089 |
0.0405 |
2.6858 |
2.5255–2.8563 |
I79 |
I79.8 |
Disorders of arteries, arterioles, and capillaries in diseases classified elsewhere |
940 (0.2767) |
0.1426 |
0.0531 |
2.6855 |
1.9159–3.7643 |
M80 |
M80.88XS |
Osteoporosis with current pathological fracture |
1227 (0.3611) |
0.1418 |
0.0530 |
2.6752 |
1.9881–3.5997 |
I44 |
I44.0 |
Atrioventricular and left bundle-branch block |
14 983 (4.4097) |
0.1324 |
0.0497 |
2.6653 |
2.4270–2.9270 |
N26 |
N26.1 |
Unspecified contracted kidney |
757 (0.2228) |
0.1413 |
0.0531 |
2.6602 |
1.8232–3.8816 |
J80 |
J80. |
Acute respiratory distress syndrome |
1161 (0.3417) |
0.1404 |
0.0530 |
2.6474 |
1.9479–3.5981 |
C90 |
C90.00 |
Multiple myeloma and malignant plasma cell neoplasms |
1041 (0.3064) |
0.1402 |
0.0531 |
2.6431 |
1.9115–3.6547 |
C22 |
C22.0 |
Malignant neoplasm of liver and intrahepatic bile ducts |
1150 (0.3385) |
0.1400 |
0.0530 |
2.6397 |
1.9385–3.5947 |
Y82 |
Y82.8 |
Other and unspecified medical devices associated with adverse incidents |
1007 (0.2964) |
0.1400 |
0.0531 |
2.6383 |
1.8972–3.6688 |
I35 |
I35.0 |
Nonrheumatic aortic valve disorders |
12 454 (3.6654) |
0.1320 |
0.0503 |
2.6225 |
2.3688–2.9033 |
C32 |
C32.9 |
Malignant neoplasm of larynx |
930 (0.2737) |
0.1387 |
0.0531 |
2.6125 |
1.8504–3.6883 |
I08 |
I08.0 |
Multiple valve diseases |
3548 (1.0442) |
0.1370 |
0.0524 |
2.6117 |
2.1819–3.1263 |
E11 |
E11.9 |
Type 2 diabetes mellitus |
114 394 (33.6679) |
0.0902 |
0.0346 |
2.6085 |
2.4536–2.7731 |
I22 |
I22.2 |
Subsequent ST elevation (STEMI) non-ST elevation (NSTEMI) myocardial infarction |
897 (0.2640) |
0.1382 |
0.0531 |
2.6031 |
1.8311–3.7006 |
I71 |
I71.4 |
Aortic aneurysm and dissection |
12 513 (3.6828) |
0.1311 |
0.0504 |
2.6027 |
2.3505–2.8818 |
I21 |
I21.4 |
Acute myocardial infarction |
14 174 (4.1716) |
0.1297 |
0.0500 |
2.5947 |
2.3550–2.8588 |
N04 |
N04.9 |
Nephrotic syndrome |
1098 (0.3232) |
0.1375 |
0.0531 |
2.5920 |
1.8837–3.5666 |
J94 |
J94.8 |
Other pleural conditions |
726 (0.2137) |
0.1377 |
0.0531 |
2.5916 |
1.7519–3.8338 |
D04 |
D04.9 |
Carcinoma in situ of skin |
3845 (1.1316) |
0.1355 |
0.0524 |
2.5864 |
2.1733–3.0780 |
E87 |
E87.6 |
Other disorders of fluid, electrolyte, and acid–base balance |
54 353 (15.9969) |
0.1097 |
0.0426 |
2.5770 |
2.4185–2.7459 |
R60 |
R60.0 |
Edema, not elsewhere classified |
61 977 (18.2408) |
0.1065 |
0.0415 |
2.5673 |
2.4126–2.7320 |
T45 |
T45.1X5A |
Poisoning by, adverse effect of and underdosing of primarily systemic and hematological agents, not elsewhere classified |
2220 (0.6534) |
0.1351 |
0.0528 |
2.5598 |
2.0383–3.2146 |
W01 |
W01.0XXA |
Fall on same level from slipping, tripping and stumbling |
9034 (2.6588) |
0.1311 |
0.0512 |
2.5594 |
2.2742–2.8805 |
C85 |
C85.80 |
Other specified and unspecified types of non-Hodgkin’s lymphoma |
2228 (0.6557) |
0.1351 |
0.0528 |
2.5592 |
2.0386–3.2127 |
H34 |
H34.219 |
Retinal vascular occlusions |
7070 (2.0808) |
0.1321 |
0.0517 |
2.5575 |
2.2414–2.9181 |
J18 |
J18.9 |
Pneumonia, unspecified organism |
32 422 (9.5423) |
0.1187 |
0.0464 |
2.5551 |
2.3768–2.7467 |
Z45 |
Z45.2 |
Encounter for adjustment and management of implanted device |
11 371 (3.3467) |
0.1290 |
0.0507 |
2.5442 |
2.2854–2.8322 |
I74 |
I74.3 |
Arterial embolism and thrombosis |
3254 (0.9577) |
0.1337 |
0.0526 |
2.5438 |
2.1033–3.0764 |
T86 |
T86.10 |
Complications of transplanted organs and tissues |
1392 (0.4097) |
0.1343 |
0.0530 |
2.5349 |
1.9012–3.3798 |
E08 |
E08.42 |
Diabetes due to underlying condition |
20 437 (6.0149) |
0.1237 |
0.0488 |
2.5346 |
2.3283–2.7591 |
J93 |
J93.83 |
Pneumothorax and air leak |
1123 (0.3305) |
0.1345 |
0.0531 |
2.5341 |
1.8406–3.4889 |
A40 |
A40.9 |
Streptococcal sepsis |
789 (0.2322) |
0.1343 |
0.0531 |
2.5281 |
1.7269–3.7010 |
C67 |
C67.9 |
Malignant neoplasm of bladder |
4135 (1.2170) |
0.1323 |
0.0524 |
2.5266 |
2.1310–2.9956 |
C18 |
C18.9 |
Malignant neoplasm of colon |
4296 (1.2644) |
0.1318 |
0.0523 |
2.5179 |
2.1295–2.9771 |
T44 |
T44.7X5A |
Poisoning by, adverse effect of and underdosing of drugs primarily affecting the autonomic nervous system |
831 (0.2446) |
0.1336 |
0.0531 |
2.5139 |
1.7318–3.6493 |
R27 |
R27.0 |
Other lack of coordination |
5819 (1.7126) |
0.1306 |
0.0520 |
2.5125 |
2.1722–2.9061 |
Z93 |
Z93.3 |
Artificial opening status |
4186 (1.2320) |
0.1312 |
0.0524 |
2.5048 |
2.1131–2.9692 |
Z89 |
Z89.519 |
Acquired absence of limb |
5730 (1.6864) |
0.1302 |
0.0520 |
2.5031 |
2.1612–2.8992 |
Z43 |
Z43.3 |
Encounter for attention to artificial openings |
2992 (0.8806) |
0.1317 |
0.0526 |
2.5019 |
2.0489–3.0550 |
E10 |
E10.9 |
Type 1 diabetes mellitus |
20 517 (6.0385) |
0.1220 |
0.0489 |
2.4951 |
2.2911–2.7172 |
H35 |
H35.31 |
Other retinal disorders |
60 393 (17.7746) |
0.1051 |
0.0421 |
2.4933 |
2.3418–2.6547 |
I38 |
I38. |
Endocarditis, valve unspecified |
2607 (0.7673) |
0.1312 |
0.0527 |
2.4880 |
2.0084–3.0820 |
I24 |
I24.8 |
Other acute ischemic heart diseases |
3221 (0.9480) |
0.1307 |
0.0526 |
2.4854 |
2.0481–3.0160 |
C25 |
C25.9 |
Malignant neoplasm of pancreas |
636 (0.1872) |
0.1321 |
0.0532 |
2.4835 |
1.6181–3.8117 |
I77 |
I77.1 |
Other disorders of arteries and arterioles |
7515 (2.2118) |
0.1280 |
0.0516 |
2.4789 |
2.1759–2.8241 |
R32 |
R32. |
Unspecified urinary incontinence |
18 819 (5.5387) |
0.1220 |
0.0493 |
2.4746 |
2.2651–2.7034 |
I66 |
I66.9 |
Occlusion and stenosis of cerebral arteries, not resulting in cerebral infarction |
883 (0.2599) |
0.1314 |
0.0531 |
2.4728 |
1.7165–3.5623 |
G12 |
G12.21 |
Spinal muscular atrophy and related syndromes |
685 (0.2016) |
0.1314 |
0.0532 |
2.4710 |
1.6331–3.7387 |
I42 |
I42.9 |
Cardiomyopathy |
15 337 (4.5139) |
0.1234 |
0.0500 |
2.4677 |
2.2418–2.7164 |
I72 |
I72.3 |
Other aneurysm |
3524 (1.0372) |
0.1294 |
0.0525 |
2.4632 |
2.0446–2.9675 |
I05 |
I05.8 |
Rheumatic mitral valve diseases |
1041 (0.3064) |
0.1306 |
0.0531 |
2.4607 |
1.7558–3.4485 |
F09 |
F09. |
Unspecified mental disorder due to known physiological condition |
2150 (0.6328) |
0.1298 |
0.0528 |
2.4557 |
1.9380–3.1118 |
R77 |
R77.0 |
Other abnormalities of plasma proteins |
1284 (0.3779) |
0.1301 |
0.0530 |
2.4522 |
1.8076–3.3266 |
D62 |
D62. |
Acute posthemorrhagic anemia |
6406 (1.8854) |
0.1266 |
0.0519 |
2.4383 |
2.1167–2.8087 |
M86 |
M86.9 |
Osteomyelitis |
7523 (2.2141) |
0.1252 |
0.0517 |
2.4219 |
2.1227–2.7632 |
J43 |
J43.9 |
Emphysema |
9950 (2.9284) |
0.1238 |
0.0512 |
2.4182 |
2.1523–2.7169 |
I87 |
I87.2 |
Other disorders of veins |
23 285 (6.8531) |
0.1175 |
0.0486 |
2.4162 |
2.2250–2.6239 |
M81 |
M81.0 |
Osteoporosis without current pathological fracture |
10 016 (2.9479) |
0.1236 |
0.0512 |
2.4143 |
2.1494–2.7118 |
K72 |
K72.90 |
Hepatic failure, not elsewhere classified |
1867 (0.5495) |
0.1275 |
0.0529 |
2.4089 |
1.8641–3.1128 |
W19 |
W19.XXXA |
Unspecified fall |
21 689 (6.3834) |
0.1178 |
0.0489 |
2.4085 |
2.2128–2.6214 |
D38 |
D38.1 |
Neoplasm of uncertain behavior of middle ear and respiratory and intrathoracic organs |
1841 (0.5418) |
0.1271 |
0.0529 |
2.4015 |
1.8543–3.1101 |
T83 |
T83.098A |
Complications of genitourinary prosthetic devices, implants, and grafts |
3957 (1.1646) |
0.1259 |
0.0525 |
2.3983 |
2.0056–2.8679 |
I07 |
I07.1 |
Rheumatic tricuspid valve diseases |
3276 (0.9642) |
0.1258 |
0.0526 |
2.3898 |
1.9643–2.9075 |
M31 |
M31.6 |
Other necrotizing vasculopathies |
1113 (0.3276) |
0.1267 |
0.0531 |
2.3863 |
1.7117–3.3268 |
T38 |
T38.0X5A |
Poisoning by, adverse effect of and underdosing of hormones and their synthetic substitutes and antagonists, not elsewhere classified |
2095 (0.6166) |
0.1260 |
0.0529 |
2.3831 |
1.8674–3.0411 |
E09 |
E09.65 |
Drug- or chemical-induced diabetes mellitus |
893 (0.2628) |
0.1265 |
0.0531 |
2.3814 |
1.6435–3.4506 |
E63 |
E63.9 |
Other nutritional deficiencies |
1355 (0.3988) |
0.1255 |
0.0530 |
2.3654 |
1.7469–3.2027 |
H90 |
H90.3 |
Conductive and sensorineural hearing loss |
118 138 (34.7698) |
0.0855 |
0.0362 |
2.3616 |
2.2218–2.5102 |
I61 |
I61.9 |
Nontraumatic intracerebral hemorrhage |
1197 (0.3523) |
0.1253 |
0.0531 |
2.3610 |
1.7102–3.2595 |
G46 |
G46.4 |
Vascular syndromes of brain in cerebrovascular diseases |
4838 (1.4239) |
0.1234 |
0.0523 |
2.3586 |
2.0018–2.7791 |
R13 |
R13.10 |
Aphasia and dysphagia |
40 814 (12.0122) |
0.1080 |
0.0459 |
2.3554 |
2.1977–2.5245 |
C20 |
C20. |
Malignant neoplasm of rectum |
935 (0.2752) |
0.1251 |
0.0531 |
2.3552 |
1.6352–3.3920 |
E21 |
E21.3 |
Hyperparathyroidism and other disorders of the parathyroid gland |
4412 (1.2985) |
0.1233 |
0.0524 |
2.3526 |
1.9817–2.7930 |
K94 |
K94.23 |
Complications of artificial openings of the digestive system |
1165 (0.3429) |
0.1245 |
0.0531 |
2.3446 |
1.6888–3.2551 |
S37 |
S37.009A |
Injury of urinary and pelvic organs |
989 (0.2911) |
0.1244 |
0.0531 |
2.3412 |
1.6399–3.3423 |
S81 |
S81.009A |
Open wound of knee and lower leg |
8362 (2.4611) |
0.1208 |
0.0516 |
2.3395 |
2.0586–2.6588 |
D89 |
D89.9 |
Other disorders involving the immune mechanism, not elsewhere classified |
1590 (0.4680) |
0.1239 |
0.0530 |
2.3378 |
1.7633–3.0995 |
G45 |
G45.9 |
Transient cerebral ischemic attacks and related syndromes |
14 740 (4.3382) |
0.1178 |
0.0504 |
2.3365 |
2.1140–2.5823 |
Y84 |
Y84.8 |
Other medical procedures as the cause of abnormal reaction of the patient or of later complication, without mention of misadventure at the time of procedure |
3576 (1.0525) |
0.1228 |
0.0526 |
2.3343 |
1.9295–2.8240 |
R47 |
R47.1 |
Speech disturbances, not elsewhere classified |
8462 (2.4905) |
0.1204 |
0.0516 |
2.3330 |
2.0539–2.6500 |
I45 |
I45.10 |
Other conduction disorders |
15 283 (4.4980) |
0.1173 |
0.0503 |
2.3302 |
2.1113–2.5718 |
G81 |
G81.90 |
Hemiplegia and hemiparesis |
3445 (1.0139) |
0.1225 |
0.0526 |
2.3279 |
1.9171–2.8267 |
R41 |
R41.2 |
Other symptoms and signs involving cognitive functions and awareness |
42 168 (12.4107) |
0.1065 |
0.0458 |
2.3270 |
2.1720–2.4930 |
I11 |
I11.9 |
Hypertensive heart disease |
28 332 (8.3385) |
0.1117 |
0.0480 |
2.3255 |
2.1510–2.5142 |
Q84 |
Q84.5 |
Other congenital malformations of integument |
1698 (0.4997) |
0.1231 |
0.0530 |
2.3233 |
1.7664–3.0557 |
Q27 |
Q27.9 |
Other congenital malformations of peripheral vascular system |
1138 (0.3349) |
0.1230 |
0.0531 |
2.3170 |
1.6589–3.2362 |
J12 |
J12.9 |
Viral pneumonia, not elsewhere classified |
1835 (0.5401) |
0.1226 |
0.0530 |
2.3155 |
1.7777–3.0160 |
T36 |
T36.8X5A |
Poisoning by, adverse effect of, and underdosing of systemic antibiotics |
1254 (0.3691) |
0.1228 |
0.0531 |
2.3139 |
1.6824–3.1826 |
I99 |
I99.8 |
Other and unspecified disorders of circulatory system |
4579 (1.3477) |
0.1212 |
0.0524 |
2.3130 |
1.9511–2.7419 |
S32 |
S32.009A |
Fracture of lumbar spine and pelvis |
4732 (1.3927) |
0.1211 |
0.0524 |
2.3121 |
1.9555–2.7338 |
J95 |
J95.811 |
Intraoperative and postprocedural complications and disorders of respiratory system, not elsewhere classified |
2669 (0.7855) |
0.1218 |
0.0528 |
2.3067 |
1.8499–2.8763 |
D69 |
D69.6 |
Purpura and other hemorrhagic conditions |
15 284 (4.4983) |
0.1161 |
0.0504 |
2.3056 |
2.0880–2.5458 |
Z51 |
Z51.89 |
Encounter for aftercare and medical care |
178 296 (52.4552) |
0.0729 |
0.0317 |
2.3027 |
2.1516–2.4644 |
Z99 |
Z99.89 |
Dependence on enabling machines and devices, not elsewhere classified |
21 756 (6.4031) |
0.1133 |
0.0492 |
2.3027 |
2.1125–2.5100 |
N05 |
N05.9 |
Unspecified nephritic syndrome |
1450 (0.4268) |
0.1221 |
0.0530 |
2.3017 |
1.7091–3.0996 |
N03 |
N03.9 |
Chronic nephritic syndrome |
736 (0.2166) |
0.1223 |
0.0532 |
2.2994 |
1.5164–3.4866 |
R34 |
R34. |
Anuria and oliguria |
720 (0.2119) |
0.1222 |
0.0532 |
2.2981 |
1.5085–3.5011 |
D09 |
D09.0 |
Carcinoma in situ of other and unspecified sites |
3148 (0.9265) |
0.1210 |
0.0527 |
2.2967 |
1.8724–2.8172 |
C76 |
C76.0 |
Malignant neoplasm of other and ill-defined sites |
3221 (0.9480) |
0.1208 |
0.0527 |
2.2923 |
1.8726–2.8061 |
I37 |
I37.0 |
Nonrheumatic pulmonary valve disorders |
1552 (0.4568) |
0.1211 |
0.0530 |
2.2847 |
1.7112–3.0505 |
Z94 |
Z94.0 |
Transplanted organ and tissue status |
3033 (0.8927) |
0.1203 |
0.0527 |
2.2824 |
1.8526–2.8120 |
J16 |
J16.8 |
Pneumonia due to other infectious organisms, not elsewhere classified |
1240 (0.3650) |
0.1210 |
0.0531 |
2.2789 |
1.6494–3.1486 |
A04 |
A04.7 |
Other bacterial intestinal infections |
5175 (1.5231) |
0.1190 |
0.0523 |
2.2754 |
1.9351–2.6755 |
Z85 |
Z85.828 |
Personal history of malignant neoplasm |
43 622 (12.8386) |
0.1042 |
0.0458 |
2.2743 |
2.1233–2.4362 |
L60 |
L60.0 |
Nail disorders |
53 817 (15.8392) |
0.1007 |
0.0444 |
2.2688 |
2.1255–2.4219 |
H59 |
H59.032 |
Intraoperative and postprocedural complications and disorders of eye and adnexa, not elsewhere classified |
2323 (0.6837) |
0.1197 |
0.0529 |
2.2634 |
1.7830–2.8732 |
C77 |
C77.0 |
Secondary and unspecified malignant neoplasm of lymph nodes |
2569 (0.7561) |
0.1195 |
0.0528 |
2.2622 |
1.8024–2.8393 |
R53 |
R53.1 |
Malaise and fatigue |
65 148 (19.1740) |
0.0971 |
0.0430 |
2.2599 |
2.1221–2.4067 |
E86 |
E86.0 |
Volume depletion |
28 085 (8.2658) |
0.1091 |
0.0483 |
2.2594 |
2.0876–2.4453 |
T17 |
T17.300A |
Foreign body in respiratory tract |
842 (0.2478) |
0.1200 |
0.0532 |
2.2563 |
1.5221–3.3445 |
R80 |
R80.3 |
Proteinuria |
13 651 (4.0177) |
0.1142 |
0.0508 |
2.2489 |
2.0245–2.4983 |
Z79 |
Z79.899 |
Long-term (current) drug therapy |
147 374 (43.3744) |
0.0777 |
0.0346 |
2.2438 |
2.1065–2.3899 |
D47 |
D47.2 |
Other neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue |
5592 (1.6458) |
0.1166 |
0.0523 |
2.2306 |
1.9049–2.6119 |
N31 |
N31.9 |
Neuromuscular dysfunction of bladder, not elsewhere classified |
7306 (2.1503) |
0.1158 |
0.0520 |
2.2287 |
1.9386–2.5621 |
D50 |
D50.9 |
Iron deficiency anemia |
31 287 (9.2082) |
0.1065 |
0.0479 |
2.2208 |
2.0569–2.3978 |
S51 |
S51.809A |
Open wound of elbow and forearm |
3177 (0.9350) |
0.1171 |
0.0527 |
2.2207 |
1.8053–2.7317 |
R15 |
R15.9 |
Fecal incontinence |
3962 (1.1661) |
0.1166 |
0.0526 |
2.2176 |
1.8405–2.6720 |
I34 |
I34.0 |
Nonrheumatic mitral (valve) disorders |
11 109 (3.2695) |
0.1137 |
0.0513 |
2.2167 |
1.9744–2.4887 |
I89 |
I89.0 |
Other noninfective disorders of lymphatic vessels and lymph nodes |
5047 (1.4854) |
0.1161 |
0.0524 |
2.2165 |
1.8772–2.6172 |
H54 |
H54.7 |
Blindness and low vision |
25 803 (7.5942) |
0.1080 |
0.0488 |
2.2108 |
2.0363–2.4001 |
I15 |
I15.8 |
Secondary hypertension |
4169 (1.2270) |
0.1161 |
0.0526 |
2.2092 |
1.8411–2.6510 |
R58 |
R58. |
Hemorrhage, not elsewhere classified |
1357 (0.3994) |
0.1172 |
0.0531 |
2.2077 |
1.6115–3.0243 |
D01 |
D01.0 |
Carcinoma in situ of other and unspecified digestive organs |
2376 (0.6993) |
0.1166 |
0.0529 |
2.2045 |
1.7352–2.8007 |
R63 |
R63.4 |
Symptoms and signs concerning food and fluid intake |
34 666 (10.2027) |
0.1046 |
0.0475 |
2.2026 |
2.0448–2.3726 |
I36 |
I36.1 |
Nonrheumatic tricuspid valve disorders |
3914 (1.1519) |
0.1157 |
0.0526 |
2.2002 |
1.8226–2.6561) |
J13 |
J13. |
Pneumonia due to Streptococcus pneumoniae |
1115 (0.3282) |
0.1166 |
0.0531 |
2.1948 |
1.5499–3.1081 |
N28 |
N28.9 |
Other disorders of kidney and ureter, not elsewhere specified |
27 416 (8.0689) |
0.1067 |
0.0486 |
2.1941 |
2.0241–2.3783 |
I43 |
I43. |
Cardiomyopathy in diseases classified elsewhere |
1050 (0.3090) |
0.1162 |
0.0531 |
2.1867 |
1.5269–3.1315 |
D68 |
D68.8 |
Other coagulation defects |
5690 (1.6747) |
0.1142 |
0.0523 |
2.1845 |
1.8648–2.5591 |
E83 |
E83.42 |
Disorders of mineral metabolism |
22 641 (6.6636) |
0.1079 |
0.0494 |
2.1827 |
2.0014–2.3806 |
E16 |
E16.2 |
Other disorders of pancreatic internal secretion |
9251 (2.7227) |
0.1126 |
0.0517 |
2.1799 |
1.9207–2.4742 |
C44 |
C44.91 |
Merkel cell carcinoma |
21 770 (6.4072) |
0.1080 |
0.0496 |
2.1778 |
1.9940–2.3785 |
H61 |
H61.23 |
Other disorders of external ear |
58 221 (17.1353) |
0.0966 |
0.0444 |
2.1776 |
2.0411–2.3232 |
I51 |
I51.7 |
Complications and ill-defined descriptions of heart disease |
24 480 (7.2048) |
0.1066 |
0.0492 |
2.1674 |
1.9918–2.3584 |
Z46 |
Z46.1 |
Encounter for fitting and adjustment of other devices |
98 123 (28.8791) |
0.0863 |
0.0399 |
2.1625 |
2.0355–2.2975 |
H52 |
H52.4 |
Disorders of refraction and accommodation |
192 666 (56.7045) |
0.0694 |
0.0323 |
2.1442 |
2.0003–2.2985 |
D41 |
D41.4 |
Neoplasm of uncertain behavior of urinary organs |
3097 (0.9115) |
0.1130 |
0.0528 |
2.1412 |
1.7289–2.6517 |
E20 |
E20.1 |
Hypoparathyroidism |
1647 (0.4847) |
0.1135 |
0.0530 |
2.1408 |
1.6002–2.8640 |
C61 |
C61. |
Malignant neoplasm of prostate |
19 707 (5.8001) |
0.1069 |
0.0500 |
2.1359 |
1.9473–2.3427 |
K55 |
K55.20 |
Vascular disorders of intestine |
2499 (0.7355) |
0.1128 |
0.0529 |
2.1336 |
1.6821–2.7064 |
B96 |
B96.81 |
Other bacterial agents as the cause of diseases classified elsewhere |
20 262 (5.9634) |
0.1066 |
0.0500 |
2.1330 |
1.9466–2.3373 |
B95 |
B95.61 |
Streptococcus, Staphylococcus, and Enterococcus as the cause of diseases classified elsewhere |
13 437 (3.9547) |
0.1086 |
0.0511 |
2.1267 |
1.9078–2.3708 |
N32 |
N32.81 |
Other disorders of bladder |
19 165 (5.6405) |
0.1063 |
0.0502 |
2.1188 |
1.9291–2.3272 |
E13 |
E13.9 |
Other specified diabetes mellitus |
11 229 (3.3049) |
0.1089 |
0.0514 |
2.1177 |
1.8824–2.3824 |
T85 |
T85.398A |
Complications of other internal prosthetic devices, implants and grafts |
3710 (1.0919) |
0.1113 |
0.0527 |
2.1128 |
1.7342–2.5739 |
I85 |
I85.00 |
Esophageal varices |
2480 (0.7299) |
0.1117 |
0.0529 |
2.1114 |
1.6608–2.6842 |
W18 |
W18.49XA |
Other slipping, tripping, and stumbling and falls |
13 407 (3.9459) |
0.1077 |
0.0511 |
2.1079 |
1.8898–2.3511 |
R29 |
R29.6 |
Other symptoms and signs involving the nervous and musculoskeletal systems |
19 639 (5.7801) |
0.1055 |
0.0501 |
2.1035 |
1.9164–2.3089 |
H02 |
H02.839 |
Other disorders of eyelid |
29 211 (8.5972) |
0.1024 |
0.0487 |
2.1019 |
1.9401–2.2772 |
B35 |
B35.1 |
Dermatophytosis |
95 767 (28.1857) |
0.0854 |
0.0407 |
2.0963 |
1.9729–2.2274 |
G99 |
G99.0 |
Other disorders of nervous system in diseases classified elsewhere |
4227 (1.2441) |
0.1100 |
0.0526 |
2.0908 |
1.7351–2.5194 |
K26 |
K26.9 |
Duodenal ulcer |
3428 (1.0089) |
0.1103 |
0.0527 |
2.0904 |
1.7008–2.5693 |
I31 |
I31.9 |
Other diseases of pericardium |
3328 (0.9795) |
0.1103 |
0.0528 |
2.0899 |
1.6953–2.5764 |
H49 |
H49.20 |
Paralytic strabismus |
1988 (0.5851) |
0.1107 |
0.0530 |
2.0883 |
1.5957–2.7330 |
T87 |
T87.89 |
Complications peculiar to reattachment and amputation |
1707 (0.5024) |
0.1107 |
0.0530 |
2.0875 |
1.5620–2.7898 |
L62 |
L62. |
Nail disorders in diseases classified elsewhere |
1530 (0.4503) |
0.1105 |
0.0531 |
2.0813 |
1.5318–2.8279 |
N47 |
N47.6 |
Disorders of prepuce |
6273 (1.8462) |
0.1086 |
0.0523 |
2.0761 |
1.7776–2.4247 |
N39 |
N39.0 |
Other disorders of urinary system |
64 087 (18.8618) |
0.0920 |
0.0444 |
2.0733 |
1.9446–2.2105 |
T46 |
T46.4X5A |
Poisoning by, adverse effect of and underdosing of agents primarily affecting the cardiovascular system |
1931 (0.5683) |
0.1098 |
0.0530 |
2.0712 |
1.5746–2.7244 |
Z16 |
Z16.11 |
Resistance to antimicrobial drugs |
2546 (0.7493) |
0.1092 |
0.0529 |
2.0638 |
1.6235–2.6234 |
I82 |
I82.409 |
Other venous embolism and thrombosis |
14 028 (4.1287) |
0.1046 |
0.0511 |
2.0456 |
1.8351–2.2803 |
N12 |
N12. |
Tubulo-interstitial nephritis, not specified as acute or chronic |
1965 (0.5783) |
0.1084 |
0.0530 |
2.0449 |
1.5552–2.6887 |
S91 |
S91.309A |
Open wound of ankle, foot, and toes |
11 184 (3.2916) |
0.1054 |
0.0516 |
2.0447 |
1.8135–2.3054 |
H21 |
H21.81 |
Other disorders of iris and ciliary body |
5158 (1.5181) |
0.1072 |
0.0525 |
2.0422 |
1.7199–2.4248 |
H01 |
H01.009 |
Other inflammation of eyelid |
31 384 (9.2368) |
0.0992 |
0.0487 |
2.0391 |
1.8843–2.2066 |
I97 |
I97.710 |
Intraoperative and postprocedural complications and disorders of circulatory system, not elsewhere classified |
2682 (0.7894) |
0.1078 |
0.0529 |
2.0371 |
1.6095–2.5783 |
L85 |
L85.3 |
Other epidermal thickening |
31 066 (9.1432) |
0.0991 |
0.0487 |
2.0350 |
1.8799–2.2029 |
M15 |
M15.9 |
Polyosteoarthritis |
70 950 (20.8817) |
0.0892 |
0.0439 |
2.0333 |
1.9090–2.1656 |
I20 |
I20.8 |
Angina pectoris |
31 188 (9.1791) |
0.0990 |
0.0487 |
2.0318 |
1.8770–2.1993 |
N13 |
N13.30 |
Obstructive and reflux uropathy |
13 082 (3.8502) |
0.1040 |
0.0513 |
2.0264 |
1.8109–2.2676 |
L57 |
L57.0 |
Skin changes due to chronic exposure of nonionizing radiation |
46 813 (13.7778) |
0.0945 |
0.0467 |
2.0227 |
1.8866–2.1685 |
G60 |
G60.9 |
Hereditary and idiopathic neuropathy |
30 297 (8.9169) |
0.0988 |
0.0489 |
2.0219 |
1.8661–2.1907 |
M10 |
M10.9 |
Gout |
32 778 (9.6471) |
0.0981 |
0.0485 |
2.0210 |
1.8693–2.1849 |
M1A |
M1A.9XX0 |
Chronic gout |
5350 (1.5746) |
0.1060 |
0.0525 |
2.0192 |
1.7039–2.3928 |
I26 |
I26.99 |
Pulmonary embolism |
7323 (2.1553) |
0.1051 |
0.0522 |
2.0148 |
1.7400–2.3330 |
K56 |
K56.60 |
Paralytic ileus and intestinal obstruction without hernia |
8535 (2.5120) |
0.1047 |
0.0520 |
2.0141 |
1.7569–2.3090 |
G58 |
G58.9 |
Other mononeuropathies |
20 738 (6.1035) |
0.1011 |
0.0502 |
2.0134 |
1.8348–2.2093 |
D30 |
D30.3 |
Benign neoplasm of urinary organs |
1931 (0.5683) |
0.1067 |
0.0530 |
2.0119 |
1.5228–2.6581 |
K59 |
K59.00 |
Other functional intestinal disorders |
59 540 (17.5235) |
0.0911 |
0.0453 |
2.0108 |
1.8833–2.1469 |
R01 |
R01.1 |
Cardiac murmurs and other cardiac sounds |
14 466 (4.2576) |
0.1028 |
0.0511 |
2.0104 |
1.8045–2.2398 |
I47 |
I47.1 |
Paroxysmal tachycardia |
12 549 (3.6934) |
0.1031 |
0.0514 |
2.0053 |
1.7873–2.2500 |
L11 |
L11.0 |
Other acantholytic disorders |
16 439 (4.8382) |
0.1020 |
0.0509 |
2.0047 |
1.8095–2.2209 |
I49 |
I49.9 |
Other cardiac arrhythmias |
59 805 (17.6015) |
0.0907 |
0.0453 |
2.0015 |
1.8746–2.1370 |
M62 |
M62.81 |
Other disorders of muscle |
71 400 (21.0141) |
0.0882 |
0.0441 |
2.0014 |
1.8789–2.1319 |
G82 |
G82.20 |
Paraplegia (paraparesis) and quadriplegia (quadriparesis) |
2430 (0.7152) |
0.1058 |
0.0530 |
1.9973 |
1.5557–2.5643 |
J98 |
J98.4 |
Other respiratory disorders |
35 483 (10.4432) |
0.0964 |
0.0483 |
1.9959 |
1.8494–2.1540 |
C64 |
C64.9 |
Malignant neoplasm of kidney, except renal pelvis |
3149 (0.9268) |
0.1048 |
0.0528 |
1.9829 |
1.5896–2.4736 |
H91 |
H91.90 |
Other and unspecified hearing loss |
71 156 (20.9423) |
0.0876 |
0.0443 |
1.9790 |
1.8576–2.1083 |
E53 |
E53.8 |
Deficiency of other B group vitamins |
19 291 (5.6776) |
0.0996 |
0.0505 |
1.9712 |
1.7899–2.1710 |
R44 |
R44.0 |
Other symptoms and signs involving general sensations and perceptions |
4298 (1.2650) |
0.1038 |
0.0527 |
1.9697 |
1.6273–2.3841 |
R97 |
R97.2 |
Abnormal tumor markers |
36 803 (10.8317) |
0.0950 |
0.0483 |
1.9694 |
1.8259–2.1241 |
R91 |
R91.8 |
Abnormal diagnostic imaging of lung |
37 585 (11.0618) |
0.0947 |
0.0482 |
1.9658 |
1.8235–2.1193 |
H40 |
H40.009 |
Glaucoma |
61 759 (18.1766) |
0.0889 |
0.0454 |
1.9583 |
1.8344–2.0905 |
I16 |
I16.0 |
Hypertensive crisis |
5096 (1.4998) |
0.1024 |
0.0526 |
1.9481 |
1.6320–2.3254 |
Q61 |
Q61.00 |
Cystic kidney disease |
7172 (2.1108) |
0.1018 |
0.0523 |
1.9467 |
1.6744–2.2634 |
D49 |
D49.2 |
Neoplasms of unspecified behavior |
14 001 (4.1207) |
0.0998 |
0.0513 |
1.9437 |
1.7390–2.1726 |
Z76 |
Z76.0 |
Persons encountering health services in other circumstances |
161 461 (47.5204) |
0.0715 |
0.0369 |
1.9405 |
1.8214–2.0674 |
D07 |
D07.5 |
Carcinoma in situ of other and unspecified genital organs |
9818 (2.8896) |
0.1006 |
0.0519 |
1.9381 |
1.7008–2.2086 |
K74 |
K74.60 |
Fibrosis and cirrhosis of liver |
8439 (2.4837) |
0.1010 |
0.0521 |
1.9372 |
1.6840–2.2285 |
K83 |
K83.1 |
Other diseases of biliary tract |
3048 (0.8971) |
0.1024 |
0.0529 |
1.9355 |
1.5416–2.4301 |
Z86 |
Z86.010 |
Personal history of certain other diseases |
103 774 (30.5422) |
0.0803 |
0.0415 |
1.9350 |
1.8211–2.0561 |
N42 |
N42.9 |
Other and unspecified disorders of prostate |
10 264 (3.0208) |
0.1003 |
0.0519 |
1.9328 |
1.7003–2.1972 |
Y83 |
Y83.1 |
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of procedure |
11 053 (3.2531) |
0.0999 |
0.0518 |
1.9296 |
1.7044–2.1845 |
L84 |
L84. |
Corns and callosities |
31 962 (9.4069) |
0.0946 |
0.0490 |
1.9284 |
1.7801–2.0891 |
R04 |
R04.0 |
Hemorrhage from respiratory passages |
14 831 (4.3650) |
0.0988 |
0.0513 |
1.9272 |
1.7282–2.1491 |
D72 |
D72.829 |
Other disorders of white blood cells |
25 660 (7.5521) |
0.0958 |
0.0499 |
1.9221 |
1.7619–2.0968 |
G93 |
G93.3 |
Oher disorders of brain |
39 656 (11.6714) |
0.0925 |
0.0482 |
1.9201 |
1.7824–2.0685 |
B02 |
B02.9 |
Zoster [herpes zoster] |
16 479 (4.8500) |
0.0976 |
0.0511 |
1.9118 |
1.7221–2.1225 |
Z92 |
Z92.3 |
Personal history of medical treatment |
8961 (2.6374) |
0.0994 |
0.0521 |
1.9092 |
1.6643–2.1900 |
N30 |
N30.00 |
Cystitis |
10 151 (2.9876) |
0.0988 |
0.0519 |
1.9027 |
1.6710–2.1666 |
R78 |
R78.89 |
Finding of drugs and other substances, not normally found in blood |
32 503 (9.5661) |
0.0933 |
0.0491 |
1.9012 |
1.7551–2.0595 |
R55 |
R55. |
Syncope and collapse |
30 812 (9.0684) |
0.0937 |
0.0493 |
1.9004 |
1.7516–2.0619 |
E03 |
E03.9 |
Other hypothyroidism |
35 891 (10.5633) |
0.0925 |
0.0487 |
1.9000 |
1.7588–2.0526 |
H04 |
H04.123 |
Disorders of lacrimal systems |
82 128 (24.1715) |
0.0830 |
0.0439 |
1.8911 |
1.7770–2.0126 |
K27 |
K27.9 |
Peptic ulcer, site unspecified |
7919 (2.3307) |
0.0987 |
0.0522 |
1.8901 |
1.6332–2.1874 |
Z60 |
Z60.2 |
Problems related to social environment |
11 811 (3.4762) |
0.0974 |
0.0517 |
1.8817 |
1.6657–2.1257 |
E27 |
E27.9 |
Other disorders of adrenal gland |
3916 (1.1525) |
0.0991 |
0.0528 |
1.8767 |
1.5290–2.3034 |
F06 |
F06.30 |
Other mental disorders due to known physiological condition |
31 408 (9.2438) |
0.0926 |
0.0493 |
1.8761 |
1.7295–2.0351 |
Z65 |
Z65.9 |
Problems related to other psychosocial circumstances |
127 694 (37.5823) |
0.0753 |
0.0401 |
1.8759 |
1.7653–1.9935 |
K25 |
K25.9 |
Gastric ulcer |
5442 (1.6017) |
0.0985 |
0.0526 |
1.8727 |
1.5718–2.2312 |
K86 |
K86.1 |
Other disorders of pancreas |
5781 (1.7014) |
0.0983 |
0.0526 |
1.8696 |
1.5768–2.2168 |
K68 |
K68.11 |
Disorders of retroperitoneum |
4165 (1.2258) |
0.0984 |
0.0528 |
1.8654 |
1.5280–2.2774 |
H18 |
H18.51 |
Other disorders of cornea |
11 506 (3.3864) |
0.0961 |
0.0518 |
1.8546 |
1.6380–2.0999 |
T81 |
T81.89XA |
Complications of procedures, not elsewhere classified |
10 309 (3.0341) |
0.0957 |
0.0520 |
1.8411 |
1.6150–2.0989 |
D51 |
D51.9 |
Vitamin B12 deficiency anemia |
14 069 (4.1407) |
0.0948 |
0.0515 |
1.8398 |
1.6416–2.0619 |
D29 |
D29.1 |
Benign neoplasm of male genital organs |
6819 (2.0069) |
0.0963 |
0.0524 |
1.8370 |
1.5670–2.1535 |
Z44 |
Z44.8 |
Encounter for fitting and adjustment of external prosthetic device |
5211 (1.5337) |
0.0967 |
0.0527 |
1.8369 |
1.5333–2.2005 |
M84 |
M84.369S |
Disorder of continuity of bone |
5832 (1.7164) |
0.0965 |
0.0526 |
1.8362 |
1.5472–2.1791 |
C43 |
C43.9 |
Malignant melanoma of skin |
4224 (1.2432) |
0.0968 |
0.0528 |
1.8345 |
1.5020–2.2405 |
R82 |
R82.5 |
Glycosuria |
14 186 (4.1752) |
0.0945 |
0.0515 |
1.8328 |
1.6357–2.0537) |
R35 |
R35.0 |
Polyuria |
39 834 (11.7237) |
0.0890 |
0.0486 |
1.8321 |
1.6989–1.9756 |
L82 |
L82.1 |
Seborrheic keratosis |
55 603 (16.3648) |
0.0859 |
0.0470 |
1.8281 |
1.7077–1.9571 |
Z91 |
Z91.19 |
Personal risk factors, not elsewhere classified |
64 332 (18.9339) |
0.0842 |
0.0461 |
1.8244 |
1.7083–1.9482 |
R49 |
R49.0 |
Voice and resonance |
12 308 (3.6224) |
0.0942 |
0.0518 |
1.8197 |
1.6114–2.0550 |
G62 |
G62.9 |
Other and unspecified polyneuropathies |
14 108 (4.1522) |
0.0937 |
0.0516 |
1.8167 |
1.6201–2.0371 |
H43 |
H43.819 |
Disorders of vitreous body |
38 102 (11.2140) |
0.0887 |
0.0489 |
1.8155 |
1.6812–1.9606 |
I83 |
I83.90 |
Varicose veins of lower extremity |
14 263 (4.1978) |
0.0934 |
0.0516 |
1.8107 |
1.6154–2.0297 |
S22 |
S22.39XA |
Fracture of rib(s), sternum, and thoracic spine |
10 436 (3.0715) |
0.0942 |
0.0520 |
1.8102 |
1.5873–2.0644 |
S31 |
S31.000A |
Open wound of abdomen, lower back, pelvis, and external genitals |
10 430 (3.0697) |
0.0942 |
0.0520 |
1.8093 |
1.5864–2.0635 |
Z13 |
Z13.6 |
Encounter for screening for other diseases and disorders |
237 211 (69.8148) |
0.0616 |
0.0341 |
1.8054 |
1.6707–1.9509 |
K57 |
K57.30 |
Diverticular disease of intestine |
60 553 (17.8217) |
0.0842 |
0.0466 |
1.8047 |
1.6880–1.9295 |
R06 |
R06.02 |
Abnormalities of breathing |
118 999 (35.0232) |
0.0750 |
0.0417 |
1.7984 |
1.6926–1.9108 |
R09 |
R09.81 |
Other symptoms and signs involving the circulatory and respiratory system |
40 481 (11.9142) |
0.0871 |
0.0488 |
1.7869 |
1.6567–1.9274 |
H31 |
H31.009 |
Other diseases of choroid |
9734 (2.8649) |
0.0931 |
0.0522 |
1.7845 |
1.5566–2.0458 |
Z23 |
Z23. |
Encounter for immunization |
260 232 (76.5902) |
0.0594 |
0.0336 |
1.7694 |
1.6229–1.9292 |
D12 |
D12.0 |
Benign neoplasm of cecum |
65 120 (19.1658) |
0.0821 |
0.0465 |
1.7646 |
1.6519–1.8850 |
K92 |
K92.1 |
Other diseases of digestive system |
40 170 (11.8226) |
0.0860 |
0.0489 |
1.7578 |
1.6287–1.8971 |
S01 |
S01.00XA |
Open wound of head |
7728 (2.2745) |
0.0921 |
0.0524 |
1.7574 |
1.5076–2.0485 |
L21 |
L21.9 |
Seborrheic dermatitis |
25 335 (7.4565) |
0.0885 |
0.0505 |
1.7534 |
1.6012–1.9200 |
R79 |
R79.89 |
Other abnormal findings of blood chemistry |
28 403 (8.3594) |
0.0879 |
0.0502 |
1.7521 |
1.6065–1.9110 |
K80 |
K80.20 |
Cholelithiasis |
16 844 (4.9574) |
0.0896 |
0.0514 |
1.7429 |
1.5645–1.9417 |
R31 |
R31.9 |
Hematuria |
42 562 (12.5266) |
0.0844 |
0.0489 |
1.7277 |
1.6025–1.8627 |
L03 |
L03.90 |
Cellulitis and acute lymphangitis |
70 833 (20.8472) |
0.0800 |
0.0463 |
1.7269 |
1.6183–1.8429 |
R42 |
R42. |
Dizziness and giddiness |
67 634 (19.9057) |
0.0800 |
0.0467 |
1.7131 |
1.6040–1.8297 |
D48 |
D48.5 |
Neoplasm of uncertain behavior of other and unspecified sites |
44 749 (13.1703) |
0.0834 |
0.0488 |
1.7106 |
1.5883–1.8424 |
Z98 |
Z98.890 |
Other postprocedural states |
92 911 (27.3451) |
0.0763 |
0.0447 |
1.7083 |
1.6057–1.8174 |
R39 |
R39.15 |
Other and unspecified symptoms and signs involving the genitourinary system |
29 413 (8.6567) |
0.0858 |
0.0503 |
1.7069 |
1.5654–1.8611 |
K31 |
K31.89 |
Other diseases of stomach and duodenum |
15 241 (4.4857) |
0.0872 |
0.0517 |
1.6854 |
1.5028–1.8900 |
M89 |
M89.9 |
Other disorders of bone |
17 841 (5.2509) |
0.0863 |
0.0515 |
1.6760 |
1.5056–1.8657 |
R25 |
R25.2 |
Abnormal involuntary movements |
28 206 (8.3014) |
0.0846 |
0.0505 |
1.6743 |
1.5323–1.8294 |
R69 |
R69. |
Illness, unspecified |
161 563 (47.5504) |
0.0675 |
0.0405 |
1.6691 |
1.5685–1.7761 |
Z09 |
Z09. |
Encounter for follow-up exam after treatment for conditions other than malignant neoplasm |
55 214 (16.2503) |
0.0803 |
0.0481 |
1.6682 |
1.5555–1.7891 |
Z48 |
Z48.02 |
Encounter for other postprocedural aftercare |
78 659 (23.1505) |
0.0770 |
0.0462 |
1.6660 |
1.5627–1.7760 |
M20 |
M20.40 |
Acquired deformities of fingers and toes |
43 692 (12.8592) |
0.0811 |
0.0492 |
1.6482 |
1.5280–1.7779 |
L98 |
L98.9 |
Other disorders of skin and subcutaneous tissue, not elsewhere classified |
55 257 (16.2630) |
0.0784 |
0.0485 |
1.6182 |
1.5080–1.7365 |
M19 |
M19.90 |
Other and unspecified osteoarthritis |
89 625 (26.3780) |
0.0737 |
0.0460 |
1.6021 |
1.5046–1.7059 |
F12 |
F12.10 |
Cannabis-related disorders |
24 113 (7.0968) |
0.0346 |
0.0548 |
0.6324 |
0.5463–0.7320 |
K58 |
K58.9 |
Irritable bowel syndrome |
17 352 (5.1070) |
0.0329 |
0.0544 |
0.6046 |
0.5071–0.7207 |
R51 |
R51. |
Headache |
51 370 (15.1190) |
0.0335 |
0.0569 |
0.5896 |
0.5310–0.6546 |
L70 |
L70.0 |
Acne |
12 335 (3.6304) |
0.0317 |
0.0541 |
0.5854 |
0.4739–0.7233 |
M22 |
M22.40 |
Disorder of patella |
16 168 (4.7585) |
0.0317 |
0.0544 |
0.5820 |
0.4835–0.7005 |
F15 |
F15.20 |
Other stimulant-related disorders |
8910 (2.6223) |
0.0300 |
0.0540 |
0.5554 |
0.4302–0.7168 |
Z56 |
Z56.0 |
Problems related to employment and unemployment |
34 996 (10.2998) |
0.0298 |
0.0560 |
0.5319 |
0.4661–0.6069 |
A63 |
A63.0 |
Other predominantly sexually transmitted diseases, not elsewhere classified |
4871 (1.4336) |
0.0279 |
0.0537 |
0.5199 |
0.3639–0.7428 |
T74 |
T74.21XA |
Adult and child neglect and other maltreatment, confirmed |
3385 (0.9963) |
0.0278 |
0.0536 |
0.5182 |
0.3376–0.7955 |
Z20 |
Z20.828 |
Contact with and (suspected) exposure to communicable diseases |
19 317 (5.6853) |
0.0279 |
0.0549 |
0.5086 |
0.4243–0.6096 |
X50 |
X50.0XXA |
Overexertion and strenuous or repetitive movements |
3150 (0.9271) |
0.0244 |
0.0536 |
0.4561 |
0.2838–0.7327 |
J03 |
J03.90 |
Acute tonsillitis |
5855 (1.7232) |
0.0243 |
0.0538 |
0.4505 |
0.3175– 0.6391 |
A60 |
A60.9 |
Anogenital herpesviral (herpes simplex) infection |
7165 (2.1088) |
0.0241 |
0.0540 |
0.4475 |
0.3258–0.6145 |
Z31 |
Z31.5 |
Encounter for procreative management |
2984 (0.8782) |
0.0221 |
0.0536 |
0.4126 |
0.2471–0.6889 |
G43 |
G43.909 |
Migraine |
42 103 (12.3915) |
0.0231 |
0.0576 |
0.4016 |
0.3503–0.4605 |
N95 |
N95.1 |
Menopausal and other perimenopausal disorders |
9036 (2.6594) |
0.0216 |
0.0542 |
0.3982 |
0.2952–0.5371 |
R92 |
R92.8 |
Abnormal and inconclusive findings on diagnostic imaging of breast |
3749 (1.1034) |
0.0195 |
0.0537 |
0.3626 |
0.2225–0.5907 |
N60 |
N60.19 |
Benign mammary dysplasia |
3693 (1.0869) |
0.0187 |
0.0537 |
0.3479 |
0.2105–0.5748 |
A64 |
A64. |
Unspecified sexually transmitted disease |
6612 (1.9460) |
0.0180 |
0.0540 |
0.3331 |
0.2271–0.4886 |
N85 |
N85.8 |
Other noninflammatory disorders of uterus, except cervix |
3702 (1.0896) |
0.0170 |
0.0537 |
0.3167 |
0.1872–0.5360 |
N46 |
N46.9 |
Male infertility |
2364 (0.6958) |
0.0161 |
0.0536 |
0.2999 |
0.1524–0.5904 |
N84 |
N84.1 |
Polyp of female genital tract |
1403 (0.4129) |
0.0157 |
0.0535 |
0.2932 |
0.1204–0.7138 |
N73 |
N73.9 |
Other female pelvic inflammatory disease |
1373 (0.4041) |
0.0138 |
0.0535 |
0.2587 |
0.0992–0.6745 |
L68 |
L68.0 |
Hypertrichosis |
1024 (0.3014) |
0.0127 |
0.0535 |
0.2375 |
0.0745–0.7569 |
N83 |
N83.20 |
Noninflammatory disorders of ovary, fallopian tube, and broad ligament |
5025 (1.4789) |
0.0127 |
0.0539 |
0.2361 |
0.1400–0.3984 |
N89 |
N89.8 |
Other noninflammatory disorders of vagina |
4793 (1.4107) |
0.0123 |
0.0539 |
0.2283 |
0.1324–0.3937 |
D25 |
D25.9 |
Leiomyoma of uterus |
4634 (1.3639) |
0.0123 |
0.0539 |
0.2282 |
0.1311–0.3972 |
N90 |
N90.7 |
Other noninflammatory disorders of vulva and perineum |
988 (0.2908) |
0.0121 |
0.0534 |
0.2272 |
0.0680–0.7594 |
F90 |
F90.9 |
Attention-deficit hyperactivity disorders |
11 738 (3.4547) |
0.0121 |
0.0548 |
0.2207 |
0.1552–0.3139 |
A74 |
A74.9 |
Other diseases caused by Chlamydiae |
1082 (0.3184) |
0.0102 |
0.0535 |
0.1901 |
0.0539–0.6713 |
N76 |
N76.0 |
Other inflammation of vagina and vulva |
10 023 (2.9499) |
0.0098 |
0.0547 |
0.1789 |
0.1171–0.2733 |
E28 |
E28.2 |
Ovarian dysfunction |
2511 (0.7390) |
0.0088 |
0.0537 |
0.1633 |
0.0669–0.3987 |
N94 |
N94.6 |
Pain and other conditions associated with female genital organs and menstrual cycle |
9013 (2.6527) |
0.0081 |
0.0546 |
0.1484 |
0.0908–0.2425 |
N92 |
N92.0 |
Excessive, frequent, and irregular menstruation |
9748 (2.8690) |
0.0081 |
0.0547 |
0.1483 |
0.0925–0.2377 |
N77 |
N77.1 |
Vulvovaginal ulceration and inflammation in diseases classified elsewhere |
1805 (0.5312) |
0.0078 |
0.0536 |
0.1448 |
0.0473–0.4436 |
N72 |
N72. |
Inflammatory disease of cervix uteri |
1687 (0.4965) |
0.0071 |
0.0536 |
0.1328 |
0.0396–0.4452 |
R87 |
R87.619 |
Abnormal findings in specimens from female genital organs |
6501 (1.9133) |
0.0071 |
0.0542 |
0.1305 |
0.0703–0.2422 |
N80 |
N80.9 |
Endometriosis |
2081 (0.6125) |
0.0067 |
0.0536 |
0.1255 |
0.0409–0.3846 |
N87 |
N87.9 |
Dysplasia of cervix uteri |
2020 (0.5945) |
0.0064 |
0.0536 |
0.1200 |
0.0375–0.3839 |
A56 |
A56.00 |
Other sexually transmitted chlamydial diseases |
1100 (0.3237) |
0.0064 |
0.0535 |
0.1190 |
0.0244–0.5801 |
N97 |
N97.9 |
Female infertility |
1964 (0.5780) |
0.0051 |
0.0536 |
0.0950 |
0.0252–0.3578 |
Z30 |
Z30.09 |
Encounter for contraceptive management |
15 303 (4.5039) |
0.0050 |
0.0556 |
0.0893 |
0.0551–0.1446 |
N91 |
N91.2 |
Absent, scanty, and rare menstruation |
2649 (0.7796) |
0.0042 |
0.0537 |
0.0773 |
0.0218–0.2740 |
N93 |
N93.9 |
Other abnormal uterine and vaginal bleeding |
5282 (1.5546) |
0.0042 |
0.0541 |
0.0770 |
0.0315–0.1884 |
Z32 |
Z32.02 |
Encounter for pregnancy test and childbirth and childcare instruction |
6339 (1.8657) |
0.0024 |
0.0543 |
0.0436 |
0.0147–0.1289 |
Z33 |
Z33.1 |
Pregnant state |
3827 (1.1263) |
0.0010 |
0.0539 |
0.0194 |
0.0024–0.1585 |